Literature DB >> 22822714

Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers.

Selena Milicevic Sephton1, Linjing Mu, W Bernd Schweizer, Roger Schibli, Stefanie D Krämer, Simon M Ametamey.   

Abstract

In the search for an optimal fluorine-18-labeled positron emission tomography (PET) radiotracer for imaging metabotropic glutamate receptor subtype 5 (mGluR5), we have prepared a series of five α-fluorinated derivatives based on the ABP688 structural manifold by application of a two-step enolization/NFSI α-fluorination method. Their binding affinities were evaluated in vitro, and the most promising candidate (Z)-16 exhibited a K(i) of 5.7 nM and a clogP value of 2.3. The synthesis of the precursor tosylate (E)-22 revealed a preference for the (E)-configurational isomer (K(i) = 31.2 nM), and successful radiosynthesis afforded (E)-[(18)F]-16 which was used as a model PET tracer to establish plasma and PBS stability. (E)-[(18)F]-16 (K(d) = 70 nM) exhibited excellent specificity for mGluR5 in autoradiographic studies on horizontal rat brain slices in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22822714     DOI: 10.1021/jm300648b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).

Authors:  Selena Milicevic Sephton; Adrienne Müller Herde; Linjing Mu; Claudia Keller; Sonja Rüdisühli; Yves Auberson; Roger Schibli; Stefanie D Krämer; Simon M Ametamey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-20       Impact factor: 9.236

2.  Improved Syntheses of the Mglu₅ Antagonists MMPEP and MTEP Using Sonogashira Cross-Coupling.

Authors:  Boshuai Mu; Linjing Mu; Roger Schibli; Simon M Ametamey; Selena Milicevic Sephton
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.